6 Drug Stocks Unworthy of Biotech Bull Market

Description:

According to Adam Feuerstein, here are "six biotech and drug stocks with valuations reaching unsustainable levels or which, for various reasons, don't deserve an invitation to the biotech bull market party at all." Read more here.

>>Also: 6 Stocks With Double-Digits Gains and Big Dividends

>>Also: 3 Tech Turnaround Stocks for 2012

Most Viewed Portfolios

View All

Articles

5 Hated Earnings Stocks You Should Love

09.02.14 | 12:52 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

5 Stocks Poised for Big Breakouts

09.02.14 | 10:49 AM

DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or takes...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter